title: Structure determination and interception of biosynthetic intermediates for the plantazolicin class of highly discriminating antibiotics.
abstract: The soil-dwelling, plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42 is a prolific producer of complex natural products. Recently, a new FZB42 metabolite, plantazolicin (PZN), has been described as a member of the growing thiazole/oxazole-modified microcin (TOMM) family. TOMMs are biosynthesized from inactive, ribosomal peptides and undergo a series of cyclodehydrations, dehydrogenations, and other modifications to become bioactive natural products. Using high-resolution mass spectrometry, chemoselective modification, genetic interruptions, and other spectroscopic tools, we have determined the molecular structure of PZN. In addition to two conjugated polyazole moieties, the amino-terminus of PZN has been modified to N(α),N(α)-dimethylarginine. PZN exhibited a highly selective antibiotic activity toward Bacillus anthracis, but no other tested human pathogen. By altering oxygenation levels during fermentation, PZN analogues were produced that bear variability in their heterocycle content, which yielded insight into the order of biosynthetic events. Lastly, genome-mining has revealed the existence of four additional PZN-like biosynthetic gene clusters. Given their structural uniqueness and intriguing antimicrobial specificity, the PZN class of antibiotics may hold pharmacological value.
authors.forename: Katie J
authors.initials: KJ
authors.lastname: Molohon
authors.forename: Joel O
authors.initials: JO
authors.lastname: Melby
authors.forename: Jaeheon
authors.initials: J
authors.lastname: Lee
authors.forename: Bradley S
authors.initials: BS
authors.lastname: Evans
authors.forename: Kyle L
authors.initials: KL
authors.lastname: Dunbar
authors.forename: Stefanie B
authors.initials: SB
authors.lastname: Bumpus
authors.forename: Neil L
authors.initials: NL
authors.lastname: Kelleher
authors.forename: Douglas A
authors.initials: DA
authors.lastname: Mitchell
mesh_terms: D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000737:chemistry* / Q000494:pharmacology; D001407:Bacillus / Q000737:chemistry; D001408:Bacillus anthracis / Q000187:drug effects; D001430:Bacteriocins / Q000096:biosynthesis / Q000737:chemistry* / Q000494:pharmacology; D008969:Molecular Sequence Data; D005810:Multigene Family; D009842:Oligopeptides / Q000096:biosynthesis / Q000737:chemistry* / Q000494:pharmacology; D010080:Oxazoles / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D013844:Thiazoles / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D001430:Bacteriocins; D009842:Oligopeptides; D010080:Oxazoles; D013844:Thiazoles